Relafen DS (Nabumetone) for Rheumatoid Arthritis | myRAteam

Connect with others who understand.

sign up Log in
About myRAteam
Powered By

Relafen is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat the signs and symptoms of rheumatoid arthritis. Relafen may also be referred to by its drug name, nabumetone.

Relafen belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAID). Relafen is believed to work by reducing pain and inflammation caused by rheumatoid arthritis.

How do I take it?
Relafen is generally taken orally one to two times per day as prescribed by your doctor.

Relafen comes in the form of an oral tablet.

Side effects
The FDA-approved label for Relafen lists common side effects including indigestion, abdominal pain, nausea, vomiting, constipation, diarrhea, gas, dizziness, fatigue, headache, and rash.

Rare but serious side effects listed for Relafen include kidney and liver damage, gastrointestinal bleeding and ulcers, hypertension, heart attack, and serious skin reactions.

For more details about this treatment, visit:

Relafen — RxList

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in